{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T14:04:27Z","timestamp":1781013867603,"version":"3.54.1"},"reference-count":28,"publisher":"Impact Journals, LLC","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aging"],"published-print":{"date-parts":[[2022,6,30]]},"DOI":"10.18632\/aging.204141","type":"journal-article","created":{"date-parts":[[2022,6,23]],"date-time":"2022-06-23T15:11:55Z","timestamp":1655997115000},"page":"5195-5210","source":"Crossref","is-referenced-by-count":7,"title":["POC1A, prognostic biomarker of immunosuppressive microenvironment in cancer"],"prefix":"10.18632","volume":"14","author":[{"given":"Qi","family":"Zhao","sequence":"first","affiliation":[{"name":"Department of Thoracic Surgery, The Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuping","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, The Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, The Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiyan","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, The Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2022,6,23]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"359","DOI":"10.3322\/caac.21669","article-title":"Cancer Statistics, 2021.","volume":"7","author":"Jemal","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"2","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1038\/s41423-020-0488-6","article-title":"The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications.","volume":"1","author":"Zhang","year":"2020","journal-title":"Cell Mol Immunol"},{"key":"3","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.3389\/fimmu.2019.01713","article-title":"Microenvironmental Regulation of Tumor Progression and Therapeutic Response in Brain Metastasis.","volume":"1","author":"Sevenich","year":"2019","journal-title":"Front Immunol"},{"key":"4","doi-asserted-by":"publisher","first-page":"588542","DOI":"10.3389\/fonc.2020.588542","article-title":"Immune Adaptation of Colorectal Cancer Stem Cells and Their Interaction With the Tumor Microenvironment.","volume":"1","author":"Yang","year":"2020","journal-title":"Front Oncol"},{"key":"5","doi-asserted-by":"publisher","first-page":"2951","DOI":"10.1007\/s00262-021-02909-4","article-title":"Tumor immune microenvironment in brain metastases from gynecologic malignancies.","volume":"7","author":"Kolev","year":"2021","journal-title":"Cancer Immunol Immunother"},{"key":"6","doi-asserted-by":"publisher","first-page":"R921","DOI":"10.1016\/j.cub.2020.06.081","article-title":"The tumor microenvironment.","volume":"3","author":"Simon","year":"2020","journal-title":"Curr Biol"},{"key":"7","doi-asserted-by":"publisher","first-page":"2909","DOI":"10.3389\/fimmu.2018.02909","article-title":"Immunomodulation of the Tumor Microenvironment: Turn Foe Into Friend.","volume":"9","author":"Maenhout","year":"2018","journal-title":"Front Immunol"},{"key":"8","doi-asserted-by":"publisher","first-page":"4669","DOI":"10.1158\/1078-0432.CCR-20-4459","article-title":"Tumor Immune Microenvironment during Epithelial-Mesenchymal Transition.","volume":"2","author":"Mandai","year":"2021","journal-title":"Clin Cancer Res"},{"key":"9","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1091\/mbc.e08-06-0619","article-title":"Molecular architecture of the centriole proteome: the conserved WD40 domain protein POC1 is required for centriole duplication and length control.","volume":"2","author":"Marshall","year":"2009","journal-title":"Mol Biol Cell"},{"key":"10","doi-asserted-by":"publisher","first-page":"5378","DOI":"10.1093\/hmg\/ddv261","article-title":"Novel POC1A mutation in primordial dwarfism reveals new insights for centriole biogenesis.","volume":"2","author":"Ozen","year":"2015","journal-title":"Hum Mol Genet"},{"key":"11","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1111\/cge.13911","article-title":"Clinical presentation and molecular characterization of a novel patient with variant POC1A-related syndrome.","volume":"9","author":"Grammatico","year":"2021","journal-title":"Clin Genet"},{"key":"12","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1242\/jcs.111203","article-title":"Poc1A and Poc1B act together in human cells to ensure centriole integrity.","volume":"12","author":"Fry","year":"2013","journal-title":"J Cell Sci"},{"key":"13","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1002\/hep.31803","article-title":"A Transcriptomic Signature for Risk-Stratification and Recurrence Prediction in Intrahepatic Cholangiocarcinoma.","volume":"7","author":"Goel","year":"2021","journal-title":"Hepatology"},{"key":"14","doi-asserted-by":"publisher","first-page":"2228","DOI":"10.3390\/ijms20092228","article-title":"A Comprehensive Bioinformatics Analysis of UBE2C in Cancers.","volume":"2","author":"Oliviero","year":"2019","journal-title":"Int J Mol Sci"},{"key":"15","doi-asserted-by":"publisher","first-page":"W509","DOI":"10.1093\/nar\/gkaa407","article-title":"TIMER2.0 for analysis of tumor-infiltrating immune cells.","volume":"4","author":"Liu","year":"2020","journal-title":"Nucleic Acids Res"},{"key":"16","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data.","volume":"2","author":"Goldberg","year":"2012","journal-title":"Cancer Discov"},{"key":"17","doi-asserted-by":"publisher","first-page":"1902880","DOI":"10.1002\/advs.201902880","article-title":"ImmuCellAI: A Unique Method for Comprehensive T-Cell Subsets Abundance Prediction and its Application in Cancer Immunotherapy.","volume":"7","author":"Guo","year":"2020","journal-title":"Adv Sci (Weinh)"},{"key":"18","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s10555-020-09937-z","article-title":"Centrosome amplification: a quantifiable cancer cell trait with prognostic value in solid malignancies.","volume":"4","author":"Aneja","year":"2021","journal-title":"Cancer Metastasis Rev"},{"key":"19","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s10577-015-9505-5","article-title":"Centrosome amplification, chromosomal instability and cancer: mechanistic, clinical and therapeutic issues.","volume":"2","author":"Kr\u00e4mer","year":"2016","journal-title":"Chromosome Res"},{"key":"20","first-page":"3974","article-title":"Centrosome defects and genetic instability in malignant tumors.","volume":"5","author":"Doxsey","year":"1998","journal-title":"Cancer Res"},{"key":"21","doi-asserted-by":"publisher","first-page":"20130467","DOI":"10.1098\/rstb.2013.0467","article-title":"Causes and consequences of centrosome abnormalities in cancer.","volume":"36","author":"Pellman","year":"2014","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"22","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.7150\/ijbs.7.1122","article-title":"A clinical overview of centrosome amplification in human cancers.","volume":"7","author":"Chan","year":"2011","journal-title":"Int J Biol Sci"},{"key":"23","doi-asserted-by":"publisher","first-page":"2353","DOI":"10.1083\/jcb.201711191","article-title":"Centrosome amplification arises before neoplasia and increases upon p53 loss in tumorigenesis.","volume":"21","author":"Chaves","year":"2018","journal-title":"J Cell Biol"},{"key":"24","doi-asserted-by":"publisher","first-page":"18982","DOI":"10.18632\/aging.103624","article-title":"POC1A acts as a promising prognostic biomarker associated with high tumor immune cell infiltration in gastric cancer.","volume":"1","author":"Zheng","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41423-019-0306-1","article-title":"Myeloid immunosuppression and immune checkpoints in the tumor microenvironment.","volume":"1","author":"Smyth","year":"2020","journal-title":"Cell Mol Immunol"},{"key":"26","doi-asserted-by":"publisher","first-page":"e2103497","DOI":"10.1002\/adma.202103497","article-title":"Engineering Endogenous Tumor-Associated Macrophage-Targeted Biomimetic Nano-RBC to Reprogram Tumor Immunosuppressive Microenvironment for Enhanced Chemo-Immunotherapy.","volume":"3","author":"Zhou","year":"2021","journal-title":"Adv Mater"},{"key":"27","doi-asserted-by":"publisher","first-page":"e1803322","DOI":"10.1002\/adma.201803322","article-title":"Nanoengineered Immune Niches for Reprogramming the Immunosuppressive Tumor Microenvironment and Enhancing Cancer Immunotherapy.","volume":"3","author":"Lim","year":"2019","journal-title":"Adv Mater"},{"key":"28","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s13045-020-0843-1","article-title":"Myeloid-derived suppressor cells-new and exciting players in lung cancer.","volume":"1","author":"Ma","year":"2020","journal-title":"J Hematol Oncol"}],"container-title":["Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.204141","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,6]],"date-time":"2022-07-06T16:09:45Z","timestamp":1657123785000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.204141"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,23]]},"references-count":28,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,6,30]]}},"alternative-id":["204141","35748773"],"URL":"https:\/\/doi.org\/10.18632\/aging.204141","relation":{},"ISSN":["1945-4589"],"issn-type":[{"value":"1945-4589","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,23]]}}}